Chronic Respiratory Diseases and Health Expenditure: Panel Regression Analysis

Abstract

Introduction: The aim of this study is to examine the effect of chronic respiratory diseases, which is one of the non-communicable diseases, on health expenditures using the static panel regression method. Methods: The static panel data methodology was used in the study. The data set consists of annual data from 36 OECD countries covering the period 2004-2017. STATA 13.0 program was used for analysis. Results: It was concluded that the logarithm of the prevalence of chronic respiratory diseases has an econometrically significant and positive effect on the logarithm of the total amount of health expenditure per capita by purchasing power parity, on the logarithm of the total amount of public health expenditure per capita, and on the logarithm of total OOP spending per capita. Conclusion: Chronic respiratory diseases, which are among non-communicable diseases, pose financial risks in both developed and developing countries and threaten the financial continuity and effectiveness of health systems.

Keywords

• Health Expenditures
• Noncommunicable Diseases
• Panel Data
• Health Economics

Kronik Solunum Yolu Hastalıkları ve Sağlık Harcamaları: Panel Regresyon Analizi

Abstract

Giriş: Bu çalışmanın amacı, bulaşıcı olmayan hastalıklardan kronik solunum yolu hastalıklarının sağlık harcamaları üzerindeki etkisini statik panel regresyon yöntemi ile incelemektir. Yöntem: Çalışmada, statik panel veri metodolojisi kullanılmıştır. Veri seti 36 (Organisation for Economic Co-operation and Development) OECD ülkesine ait 2004-2017 dönemini kapsayan yıllık verilerden oluşmaktadır. Analizler için STATA 13,0 programı kullanılmıştır. Bulgular: Kronik solunum yolu hastalıklarının prevalansının logaritmasının, satın alma gücü paritesine göre kişi başı toplam sağlık harcaması miktarının logaritması üzerinde, kişi başı toplam kamu sağlık harcaması miktarının logaritması, ve kişi başı toplam cepten sağlık harcamasının logaritması üzerinde ekonometrik olarak anlamlı ve pozitif etkisinin olduğu sonucuna ulaşılmıştır. Sonuç: Bulaşıcı olmayan hastalıklar içinde yer alan kronik solunum yolu hastalıkları, gerek gelişmiş, gerekse de gelişmekte olan ülkelerde mali açıdan risk oluşturmakta ve sağlık sistemlerinin finansal açıdan devamlılığını ve etkinliğini tehdit etmektedirler

Keywords

• Sağlık Harcamaları
• Bulaşıcı Olmayan Hastalıklar
• Panel Veri
• Sağlık Ekonomisi

References

1. 1. Wang Q, Brenner S, Kalmus O, Banda HT, Allegri MD. The Economic Burden of Chronic Noncommunicable Diseases in Rural Malawi:An Observational Study. BMC Health Services Research 2016; 16: 1-9.
2. 2. Alwan A, Armstrong T, Bettcher D, et al. Global status report on on noncommunicable diseases 2010. Genevre: WHO. 2011.
3. 3. Lozano R, Naghavi M, Kyle Foreman, et al. Global and Regional Mortality from 235 Causes of Death for 20 Age Groups in 1990 and 2010: A Systematic Analysis for the Global Burden of Disease Study 2010. The Lancet 2012; 380(9859): 2095-2128.
4. 4. Türkiye İstatistik Kurumu. (2012). Ölüm Nedeni İstatistikleri. Available at: http://www.tuik.gov.tr/PreTablo.do?alt_id=1083 Erişim tarihi 14 Eylül 2020. (Accessed September 14, 2020.)
5. 5. Ministry of Health and World Health Organization European Office. - Multi-stakeholder Turkey NCD Action Plan 2017-2025. Ankara: TR Ministry of Health. 2017.
6. 6. Suhrcke M, Urban D. Are Cardiovascular Diseases Bad for Economic Growth? Cesıfo Workıng Paper No. 1845. 2006.
7. 7. Torun P, Kutlar A. Türkiye’de Kanserin Ekonomik Maliyetleri: Bir Hesaplanabilir Genel Denge Modeli Yaklaşımı. Hacettepe Sağlık İdaresi Dergisi 2018;21 (1): 31-39.
8. 8. Roser M., Ritchie H. Burden of disease. Our World in Data. Advance online publication. Available at: https://ourworldindata.org/burden-of-disease Erişim tarihi 10 Eylül 2020. (Accessed September 10, 2020.)

9. 9. Greene WH. Econometric Analysis. New York: Pearson Education Publication.2012.
10. 10. Yerdelen Tataoğlu F. Panel Veri Analizi. İstanbul: Beta. 2018.
11. 11. Wooldridge JM. Econometric Analysis of Cross Section and Panel Data. London: The MIT Press. 2002.
12. 12. Xu K, Saksena P, Holly A. The Determinants of Health Expenditure. Geneva: World Health Organization.2011.
13. 13. Newhouse J.Medical Care Expenditure: A Cross National Survey. Journal of Human Resources 1977;12: 115-125.
14. 14. Gerdtham U, Jonsson C. An Econometric Analysis of Health Care Expenditure, A Cross Section Study of OECD countries. Journal of Health Economics 1992;11: 63-84.
15. 15. Hitiris T, Posnett J. The Determinants and the Effects of Health Expenditure in Developed Countries. Journal of Health Economics 1992; 11: 173-181.
16. 16. Getzen T. Forecasting Health Expenditures: Short, Medium and Long Term. Journal of Health Care Finance 2000;26: 56-72.
17. 17. Baltagi BH, Moscone F. Health Care Expenditure and Income in the OECD Reconsidered: Evidence from Panel Data. Economic Modelling 2000;27(4): 804-811.
18. 18. Mutlu A, Işık A. Sağlık Ekonomisine Giriş. Bursa: Ekin Publishing.2012.
19. 19. Arun Ö.Yaşlı Bireyin Türkiye Serüveni: Kaliteli Yaşlanma İmkânı Üzerine Senaryolar. Gaziantep Üniversitesi Sosyal Bilimler Dergisi 2008;7(2): 313-330.
20. 20. Fujino S. Health economics in Japan: Prospects for the Future. In G. Smith (Eds), Health Economics: Prospects for the Future. Croom Helm. 1987.
21. 21. Seshamani M, Gray A. The Impact of Aging on Expenditures in the National Health Service. Age and Aging 2002;31: 287-294.
22. 22. Liu J, Maniadakis N, Gray A, Rayner M. The Economic Burden of Coronary Heart Disease in the UK. Heart 2002; 88(6): 597-603.
23. 23. Schmid T. Costs of Treating Cardiovascular Events in Germany: A Systematic Literature Review. Health Economics Reviews 2015; 5(1): 27.
24. 24. Vandenberghe D, Albrecht J. The Financial Burden of Non-Communicable Diseases in the European Union: A Systematic Review. European Journal of Public Health 2019;73.
25. 25. Strauss J, Thomas D. Health over the life course. In T. Schultz,, & J. Strauss (Eds), Handbook of development economics. California: University of California. 2008.
26. 26. Bloom DE, Kuhn M, Prettner K. Health and economic growth. IZA Institude of Labor Economics Paper Series 11939. 2018.
27. 27. Audibert M, Motel PC, Drabo A. Global Burden of Disease and Economic Growth. Sciences de l'Homme et de la Société 2012; (12): 1-35.
28. 28. Tandon A. Macroeconomic Impact of HIV/AIDS in the Asian and Pasific Region. ERD Workin Paper Series 2005:75; 1-29.
29. 29. Cuddington JT. Modeling The Macroeconomic Effects of AIDS, With an Application to Tanzania (English). The World Bank. 1993.
30. 30. Cuddington J, Hancock J. Assessing the Impact of AIDS on the Growth Path of the Malawian Economy. Journal of Development Economics 1994; 43(2): 363-638.
31. 31. Suhrcke M, Urban D. Are Cardiovascular Diseases Bad for Economic Growth? Health Economics 2010;19: 1478–1496.
32. 32. Abegunde D, Stanciole A. An estimation of the economic impact of chronic noncommunicable diseases in seleceted countries: World Health Organization Working Paper 2006.